Please enable Javascript to use all features and improve your user experience.
DGM 2023
Programme
People
Search
DE
All people
Dr Geert Jan van Daal
Pratteln / CH
Santhera Pharmaceuticals
Sort by Type
Date
Speaker
22/03/2023
Poster
P 95
Daily regimens of prednisone, deflazacort and vamorolone improve motor function similarly in patients with Duchenne Muscular Dystrophy
Therapie
22/03/2023
Poster
P 94
Efficacy and safety of vamorolone during 48-week treatment in patients with Duchenne Muscular Dystrophy (DMD) in the VISION-DMD study
Therapie, Varia
22/03/2023
Poster
P 96
The vertebral fracture burden in boys with DMD treated with the novel dissociative steroid vamorolone versus deflazacort and prednison. On behalf of the Ottawa Pediatric Bone Health Research Group, the FOR DMD Investigators of the Muscle Study Group and the CINRG VBP15-002/003/LTE Investigators
Therapie
Further involvements
22/03/2023
Poster
P 94
Efficacy and safety of vamorolone during 48-week treatment in patients with Duchenne Muscular Dystrophy (DMD) in the VISION-DMD study
Therapie, Varia
22/03/2023
Poster
P 95
Daily regimens of prednisone, deflazacort and vamorolone improve motor function similarly in patients with Duchenne Muscular Dystrophy
Therapie
22/03/2023
Poster
P 96
The vertebral fracture burden in boys with DMD treated with the novel dissociative steroid vamorolone versus deflazacort and prednison. On behalf of the Ottawa Pediatric Bone Health Research Group, the FOR DMD Investigators of the Muscle Study Group and the CINRG VBP15-002/003/LTE Investigators
Therapie
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy